Insight Inv LLC’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$839K Sell
8,115
-812
-9% -$72.5K 0.4% 58
2026
Q1
$641K Sell
8,927
-2,560
-22% -$197K 0.35% 63
2025
Q4
$912K Sell
11,487
-175
-2% -$13.8K 0.51% 57
2025
Q3
$879K Sell
11,662
-916
-7% -$62.8K 0.52% 58
2025
Q2
$868K Sell
12,578
-528
-4% -$34.6K 0.58% 57
2025
Q1
$888K Sell
13,106
-55
-0.4% -$3.29K 0.61% 57
2024
Q4
$591K Sell
13,161
-1,059
-7% -$59.4K 0.41% 63
2024
Q3
$894K Sell
14,220
-670
-4% -$39.1K 0.75% 52
2024
Q2
$879K Sell
14,890
-2,700
-15% -$169K 0.76% 51
2024
Q1
$1.4M Sell
17,590
-725
-4% -$55.4K 1.22% 40
2023
Q4
$1.45M Buy
18,315
+150
+0.8% +$10.7K 1.42% 35
2023
Q3
$1.28M Sell
18,165
-295
-2% -$20.9K 1.42% 34
2023
Q2
$1.28M Buy
18,460
+300
+2% +$21.3K 1.31% 41
2023
Q1
$1.35M Sell
18,160
-2,680
-13% -$225K 1.46% 35
2022
Q4
$1.94M Sell
20,840
-985
-5% -$95K 1.96% 14
2022
Q3
$2.08M Sell
21,825
-10
-0% -$990 2.31% 5
2022
Q2
$2.02M Sell
21,835
-480
-2% -$46.8K 2.04% 10
2022
Q1
$2.26M Buy
22,315
+730
+3% +$76.7K 2.05% 7
2021
Q4
$2.23M Buy
+21,585
New +$1.99M 2.05% 9

Other funds holding CVS

Insight Inv LLC's CVS Position: Q2 2026 in Review

Insight Inv LLC reduced its CVS Health (CVS) stake by 9.1% in Q2 2026, selling an estimated $72.5K and leaving 8,115 shares worth $839K. The position accounts for 0.4% of the portfolio, ranked #58.

Insight Inv LLC first reported a position in CVS in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.26M in Q1 2022. 650 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Insight Inv LLC held 8,115 shares of CVS Health worth $839K as of Q2 2026.
  • Insight Inv LLC sold 812 CVS Health shares in Q2 2026, an estimated $72.5K.
  • CVS Health made up 0.4% of Insight Inv LLC's portfolio in Q2 2026, its #58 holding.
  • Insight Inv LLC first reported a position in CVS Health in Q4 2021 and has held it in 19 quarters since.
  • Insight Inv LLC's CVS Health position peaked at $2.26M in Q1 2022.
  • 650 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Insight Inv LLC's 13F filing for Q2 2026, filed 24 Jul 2026.